Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document provides an update on the preclinical and clinical development of Immunic's product candidates, including IMU-935, highlighting future plans and risks.
investor_presentation
Norbord
ADM 2013 Investor Presentation - Annual Results
investor_presentationinvestor_presentation
4 Pages
Archer Daniels Midland Company